Product NDC: | 0093-1087 |
Proprietary Name: | Cefaclor |
Non Proprietary Name: | Cefaclor |
Active Ingredient(s): | 500 mg/1 & nbsp; Cefaclor |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-1087 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065058 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020926 |
Package NDC: | 0093-1087-01 |
Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-1087-01) |
NDC Code | 0093-1087-01 |
Proprietary Name | Cefaclor |
Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-1087-01) |
Product NDC | 0093-1087 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefaclor |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20020926 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CEFACLOR |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |